# Filomeen Haerynck

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/filomeen-haerynck/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,482 |
| Field | Immunodeficiency and Autoimmune Disorders |
| h-index | 48 |
| i10-index | 103 |
| Last Known Institution | Ghent University Hospital |
| OpenAlex ID | https://openalex.org/A5001156641 |
| ORCID iD | https://orcid.org/0000-0001-9161-7361 |
| Works | 259 |

## Researcher papers

- [Autoantibodies against type I IFNs in patients with life-threatening COVID-19](https://scholariq.org/papers/autoantibodies-against-type-i-ifns-in-patients-with-life-threatening-covid-19/)
- [Inborn errors of type I IFN immunity in patients with life-threatening COVID-19](https://scholariq.org/papers/inborn-errors-of-type-i-ifn-immunity-in-patients-with-life-threatening-covid-19/)
- [Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths](https://scholariq.org/papers/autoantibodies-neutralizing-type-i-ifns-are-present-in-4-of-uninfected/)
- [Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)](https://scholariq.org/papers/clinical-similarities-and-differences-of-patients-with-x-linked/)
- [Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study](https://scholariq.org/papers/long-term-follow-up-of-ipex-syndrome-patients-after-different-therapeutic/)
- [The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies](https://scholariq.org/papers/the-risk-of-covid-19-death-is-much-greater-and-age-dependent-with-type-i-ifn/)
- [Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children](https://scholariq.org/papers/inborn-errors-of-oas-rnase-l-in-sars-cov-2-related-multisystem-inflammatory/)
- [Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score](https://scholariq.org/papers/long-term-outcome-of-lrba-deficiency-in-76-patients-after-various-treatment/)

## Researcher topics

- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)
- [Cystic Fibrosis Research Advances](https://scholariq.org/topics/cystic-fibrosis-research-advances/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Blood disorders and treatments](https://scholariq.org/topics/blood-disorders-and-treatments/)

## Researcher university

- [Ghent University Hospital](https://scholariq.org/institutions/ghent-university-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.